Modulating factors of fibromyalgia in women during the COVID-19 pandemic A protocol for systematic review

0Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: Fibromyalgia is a disease that affects mostly women and is related to stressors. The aim of this study was to assess how the Coronavirus disease 2019 pandemic has affected women with fibromyalgia. Methods: A systematic review was conducted in the PubMed, ScienceDirect, and Springer Link databases, following the recommendations of the preferred reporting items for systematic reviews and meta-analyses statement. The methodological quality was assessed using the Joanna Briggs Institute critical appraisal tools for non-randomized studies. Results: A total of 6 studies were included. Most results indicated a worsening in the mental health of women with fibromyalgia during the pandemic, and this in turn impacted on physical health. Conclusion: The mental health of women with fibromyalgia was more affected during the Coronavirus disease 2019 pandemic period than that of non-fibromyalgia sufferers. This was also reflected in the worsening of symptoms and weakness in performing daily activities.

Cite

CITATION STYLE

APA

Núñez-Recio, I., García-Iglesias, J. J., Martín-López, C., Navarro-Abal, Y., Fagundo-Rivera, J., Climent-Rodríguez, J. A., & Gómez-Salgado, J. (2022, December 30). Modulating factors of fibromyalgia in women during the COVID-19 pandemic A protocol for systematic review. Medicine (United States). Lippincott Williams and Wilkins. https://doi.org/10.1097/MD.0000000000032577

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free